CAR T and PD-1 Knockout Engineered T Cells for Esophageal Cancer

NCT03706326 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Esophageal Cancer

Interventions

BIOLOGICAL: Anti-MUC1 CAR-T cells
BIOLOGICAL: PD-1 knockout Engineered T cells
COMBINATION_PRODUCT: CAR-T combined with PD-1 Knockout T cells

Sponsor

The First Affiliated Hospital of Guangdong Pharmaceutical University

Collaborators

[object Object]